Cargando…
Reversible Systolic Heart Failure in a Patient on Ibrutinib Chemotherapy
Ibrutinib is an irreversible Bruton tyrosine kinase inhibitor that is approved for the treatment of mantle cell lymphoma, chronic lymphocytic leukemia, small lymphocytic lymphoma, Waldenström macroglobulinemia, marginal zone lymphoma, and mantle cell lymphoma. However, it is associated with signific...
Autores principales: | Khaja, Misbahuddin, Gurjar, Hitesh, Yapor, Laura, Abraham, Minu C, Hernandez, Nolberto, Haider, Asim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013282/ https://www.ncbi.nlm.nih.gov/pubmed/35449638 http://dx.doi.org/10.7759/cureus.23266 |
Ejemplares similares
-
Hepatic Amyloidosis as a Rare Cause of Liver Failure: A Case Report
por: Ghazanfar, Haider, et al.
Publicado: (2022) -
Percutaneous Tracheostomy: A Bedside Procedure
por: Khaja, Misbahuddin, et al.
Publicado: (2022) -
Tuberculosis Presenting With Acute Myocarditis and Systolic Heart Failure
por: Choudhary, Nikhil, et al.
Publicado: (2021) -
A Rare Case of Reverse Takotsubo Cardiomyopathy in a 28-Year-Old Female in Peripartum Period
por: Khaja, Misbahuddin, et al.
Publicado: (2022) -
A High-Risk Patient With COVID-19 Vaccine Hesitancy Successfully Treated With Monoclonal Antibodies Through Two Major Surges
por: Gurjar, Hitesh, et al.
Publicado: (2022)